Product-specific advice (steroid nasal sprays) [Design Issues]

posted by Mikalai  – Belarus, 2018-10-16 11:42 (941 d 03:51 ago) – Posting: # 19451
Views: 2,283

(edited by Mikalai on 2018-10-16 13:35)

Dear friends,
Are there any explicit recommendations or guidelines from EMA about how to establish bio-equivalence for nasal sprays with steroids? More specifically, how can we avoid a therapeutic equivalence study, European approach? Are there any recommendations on Morphologically-Directed Raman Spectroscopy (MDRS) as a substitute for a therapeutic equivalence study? Any references will be appreciated.

Complete thread:

Activity
 Admin contact
21,460 posts in 4,486 threads, 1,514 registered users;
online 5 (1 registered, 4 guests [including 2 identified bots]).
Forum time: Friday 15:33 UTC (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5